Clinical studyMixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)☆
References (39)
- et al.
Protein measurement with the Folin phenol reagent
J Biol Chem
(1951) Determination of nucleic acids in animal tissues
J Biol Chem
(1955)- et al.
Immunochemical quantitation of antigens by single radial immunodiffusion
Immunochemistry
(1965) - et al.
Pathologic observations in systemic sclerosis (scleroderma)
Amer J Med
(1969) Variations in the morphological patterns of “autoimmune” nuclear fluorescence
Lancet
(1961)- et al.
Correlation of antinuclear antibodies and nuclear staining patterns
Lancet
(1961) - et al.
Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy
J Clin Invest
(1971) - et al.
An improved preparation of sodium desoxyribonucleate
J Amer Chem Soc
(1952) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid
Biochem J
(1956)Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutinationinhibition reactions with tannic acid and proteintreated red blood cells
J Immun
(1954)
Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus
J Lab Clin Med
An immunofluorescent study of the skin lesions in systemic lupus erythematosus
Arthritis Rheum
Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus
J Clin Invest
Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus
J Immun
The reaction of the lupus erythematosus (L.E.) cell factor with deoxyribonucieoprotein of the cell nucleus
J Clin Invest
Experimental Immunochemistry
Serum and cerebral spinal fluid complement and serum autoantibodies in systemic lupus erythematosus
Medicine
Progressive systemic sclerosis (diffuse scleroderma)
Systemic scleroderma
Arch Derm (Chicago)
Cited by (0)
- ☆
This work was supported in part by U.S. Public Health Service Research Grant No. AM-05425 from the National Institute of Arthritis and Metabolic Diseases and by Grant No. FR-70 from the General Clinical Research Centers Branch, Division of Research Facilities and Resources, National Institutes of Health, Bethesda, Maryland.
- ∗
Present address: Division of Immunology and Rheumatology, Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri 65201.
- 1
From the Department of Medicine, Stanford University School of Medicine, Stanford, California 94305.
- 3
From the Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri 65201.
- 2
From the Division of Allergy and Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037.